+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Veterinary Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • PDF Icon


  • 101 Pages
  • February 2024
  • Region: India
  • Mordor Intelligence
  • ID: 4997206
The India Veterinary Healthcare Market size is estimated at USD 1.25 billion in 2024, and is expected to reach USD 1.89 billion by 2029, growing at a CAGR of 8.63% during the forecast period (2024-2029).

India has been in lockdown and has suspended trade with other countries and implemented travel restrictions, which affected the import and export activities of veterinary medicines and diagnostics, leading to a decline in sales of many products. Supply disruption and medicine shortages of veterinary medicines have been observed in several regions due to the temporary lockdowns of manufacturing sites, export bans, increased demands for medicine for the treatment of COVID-19, and the stockpiling of medicines by individuals. However, the government has been taking up measures to mitigate the supply of medicines and veterinary practices during the COVID-19 pandemic. For instance, in March 2020, the Government of India stated that all states must ensure that medical help for animals is treated as an essential service, which does not get suspended during COVID-19 lockdowns across the country. Therefore, it is observed that the veterinary healthcare market was significantly hampered due to the COVID-19 pandemic. However, currently, the market has regained its pre-pandemic nature in terms of demand for veterinary products and is expected to witness strong growth in the coming years.

In India, there has been an increasing activity observed across veterinary hospitals. For instance, in August 2022, DCC (Dogs Cats & Companions) Animal Hospital, one of India's leading multi-specialty state-of-the-art pet care chains expanded with a new full-service medical and grooming center in New Delhi, India. Among the developing countries, India has the highest zoonotic disease burden, with widespread illness and death. Hence, owing to these factors, the market is expected to grow in the forecast period.

In addition, there is a growing focus from the Indian government on the betterment of livestock which is fueling the market growth. For instance, in July 2022, the Union Minister for Fisheries, Animal Husbandry, and Dairy, Shri Parshottam Rupala, recommended that the cooperative movement in the livestock industry be strengthened. In addition, there has been the implementation of various programs and schemes in India in the favor of veterinary health. For instance, some of the programs implemented currently by the Government of India include Assistance to States for Control of Animal Diseases (ASCAD), National Animal Disease Reporting System (NADRS), Establishment & Strengthening of Veterinary Hospital and Dispensaries (ESVHD), and Foot and Mouth Disease Control Program (FMD-CP), among others. Hence, with the involvement of the government in veterinary healthcare and the rising awareness about the same, the market studied is expected to witness strong growth in the coming years.

However, the use of counterfeit medicine and increasing costs of animal testing and veterinary services are some of the factors restraining market growth in the country.

Veterinary in India Market Trends

The Vaccine Segment is Expected to Have the Highest Growth Rate Over the Forecast Period

Vaccines are comprised of viruses, bacteria, or other disease-causing organisms that have been killed or altered so that they cannot cause any disease, thus, boosting immunity. Vaccines are being manufactured that contain genetically engineered components derived from those disease agents. The vaccines segment is expected to be driven by innovations in vaccines, growing awareness of animal health, increasing investments by government bodies and associations, increasing demand for animal protein, including milk, meat, eggs, and fish, and rising healthcare expenditure for companion animals.

In May 2021, Hyderabad-based Indian Immunologicals Limited (IIL) launched Raksha Class, a classical swine fever (CSF) vaccine, which is a unique cell culture technology-based vaccine for pigs, developed in collaboration with the Indian Veterinary Research Institute (IVRI), Bareilly. Additionally, there has been increasing use of technology in veterinary vaccines in India. For instance, in November 2022, Noida based startup named Tech Eagle became the world's first company to deliver vaccines to the animal husbandry department of Arunachal Pradesh with the help of a drone. Hence, with such launches in the Indian market, the segment is expected to witness strong growth.

Furthermore, in June 2022, Agriculture Minister Narendra Singh Tomar on Thursday launched the country's first homegrown COVID-19 vaccine Anocovax for animals, developed by Haryana-based ICAR-National Research Centre on Equines (NRC). The immunity induced by Anocovax neutralizes both Delta and Omicron variants of SARS-CoV-2. Hence, with such advancements in veterinary vaccines across the country, the segment is expected to witness strong growth in the future.

Increasing Pet Adoption in India is Expected to Propel the Market Growth in Coming Years

The major factor contributing to the growth of the market studied in India is the increasing pet adoption and the rising number of animals getting injured with pain and inflammatory diseases. For instance, as per the Bark India Charitable Trust, dogs and cats are the most common animals that the team has been saving since it began its project. The crew saved 82 animals in June 2022, 10 of whom received surgery before being maintained for adoption, and in August 2022, 107 sick and injured animals were rescued. Hence, the surgeries on animals increase the need for veterinary products that help the market grow in the forecast period.

As per the data from PetKeen published in August 2022, dogs are the most common pet in India, with around 34% of pet owners having a dog, whereas 20% have cats. Furthermore, the same data indicated that around 60% of people in India have a pet, with over 10 million pet dogs in the country. Despite the comparatively low adoption of cats in the country, it is estimated that by the year 2023, the number of pet cats in India will reach around 2.4 million. Hence, the statistics mentioned above indicate that there is a high rate of pet adoption in the country, which is fueling the market for veterinary healthcare in India.

Furthermore, the increased awareness of animal healthcare and pain management products in the nation is expected to drive the market. For instance, as per the data by Pashudhan Praharee published in March 2022, in the treatment of companion animals, licensed veterinary NSAIDs are used to manage the discomfort and swelling brought on by osteoarthritis in dogs and horses. The data also stated the level of knowledge about NSAIDS treatment on animals, including side effects, contraindications, and risks associated with NSAIDs in companion animals. Therefore, with the increasing use of NSAIDs in veterinary practice, the market studied is expected to witness strong growth in the coming years.

Veterinary in India Industry Overview

The Indian veterinary healthcare market is moderately competitive and consists of several major players, such as Boehringer Ingelheim GmbH, Elanco Animal Health, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol SA, Virbac, and Zoetis Inc. These companies are mostly focusing on growth strategies like collaborations, partnerships, agreements, mergers, and acquisitions to improve their market presence.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.2.2 Increasing Adoption of Pet in India
4.3 Market Restraints
4.3.1 Use of Counterfeit Medicines
4.3.2 Increasing Costs of Animal Testing and Veterinary Services
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product
5.1.1 By Therapeutics Vaccines Parasiticides Anti Infectives Medical Feed Additives Other Therapeutics
5.1.2 By Diagnostics Immunodiagnostic Tests Molecular Diagnostics Diagnostic Imaging Clinical Chemistry Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animals
6.1 Company Profiles
6.1.1 Boehringer Ingelheim GmbH
6.1.2 Elanco Animal Health
6.1.3 IDEXX Laboratories Inc.
6.1.4 Merck & Co. Inc.
6.1.5 Vetoquinol
6.1.6 Virbac
6.1.7 Zoetis Inc.
6.1.8 Zydus Cadila
6.1.9 Hester Biosciences Limited
6.1.10 Indian Immunologicals Limited

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boehringer Ingelheim GmbH
  • Elanco Animal Health
  • IDEXX Laboratories Inc.
  • Merck & Co. Inc.
  • Vetoquinol
  • Virbac
  • Zoetis Inc.
  • Zydus Cadila
  • Hester Biosciences Limited
  • Indian Immunologicals Limited